Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Nanomaterials have revolutionized biomedical and pharmaceutical technology in the past decades. Several nanomedicines have reached the clinics but the overall clinical translation is still low. Precise delivery of the pharmaceutical agent at the right time and space remains a challenge. Responsive materials can overcome this limitation by modulation of their behavior according to internal (e.g., pH) or external triggers (e.g. light). We have recently developed pH-sensitive switchable liposomes which specifically release bioactive compounds within the cell upon acidification. The endosomal escape of nucleic acids and hydrophilic compounds was significantly improved as compared to commercial agents, accompanied with a lower toxicity. In this project, we want to investigate the pH-sensitive behavior of such switchable liposomes to mechanistically understand the governing factors behind the pH-sensitive liposomes destabilization. The outcome of this research could positively contribute to the pharmaceutical field by clarifying the intracellular drug delivery mechanism of pH-sensitive liposomes.
Jeanne Leblond Chain
Université de Bordeaux
Life Sciences
Health and Related Sciences & Technology; Nanotechnology; Pharmaceuticals
Université de Montréal
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.